We are live on ! Find out more
SPRB

Spruce Biosciences
SPRB

37 hedge funds and large institutions have $94.4M invested in Spruce Biosciences in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $72M → $94.4M (+$22.4M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 38 → 37 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
8
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$1.41M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$761K
3
WVP
Worth Venture Partners
New Jersey
+$346K
4
Marshall Wace
Marshall Wace
United Kingdom
+$163K
5
Northern Trust
Northern Trust
Illinois
+$73.9K

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$2.98M
2
AC
Armistice Capital
New York
-$1.27M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$924K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$201K
5
RSCM
Rock Springs Capital Management
Maryland
-$183K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$280K -$1.04K -9 -0.7%
BCM
27
Bridgeway Capital Management
Texas
$249K – – –
State Street
28
State Street
Massachusetts
$182K – – –
MAM
29
Marquette Asset Management
Minnesota
$163K – – –
PFMU
30
Privium Fund Management (UK)
United Kingdom
$71.9K – – –
SI
31
Sofinnova Investments
California
$66.7K -$54.3K -470 -61%
Charles Schwab
32
Charles Schwab
California
$44.8K – – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$26K -$1.16K -10 -8%
Morgan Stanley
34
Morgan Stanley
New York
$12.5K +$3.35K +29 +104%
CSC
35
Caldwell Sutter Capital
California
$2.93K – – –
UBS Group
36
UBS Group
Switzerland
$1.42K +$693 +6 New
Wells Fargo
37
Wells Fargo
California
$413 – – –
Bank of America
38
Bank of America
North Carolina
$38 -$462 -4 Closed
JP Morgan Chase
39
JP Morgan Chase
New York
$32 – – –
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$6 – – –
Verition Fund Management
41
Verition Fund Management
Connecticut
– -$2.98M -17,592 Closed
Bank of New York Mellon
42
Bank of New York Mellon
New York
– -$201K -1,188 Closed
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
– -$73.3K -433 Closed
TRCT
44
Tower Research Capital (TRC)
New York
– -$9.85K -58 Closed
Fidelity Investments
45
Fidelity Investments
Massachusetts
– -$82 – –
1
2

SPRB Hedge Fund Activity: Q4 2023 in Review

37 of the 6,864 institutional investors tracked by Wall St. Rank reported a position in Spruce Biosciences (SPRB) for Q4 2023, worth a combined $94.4M — up 31% from $72M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of SPRB and 4 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 8 added.

The largest buyer was AIGH Capital Management, adding an estimated $1.41M. The largest seller was Verition Fund Management, exiting entirely with an estimated $2.98M sold.

  • 37 institutional investors held Spruce Biosciences (SPRB) as of Q4 2023, down from 38 in Q3 2023.
  • Funds reported $94.4M of Spruce Biosciences stock for Q4 2023, up 31% quarter-over-quarter.
  • 4 funds opened new Spruce Biosciences positions in Q4 2023 and 5 closed out, a net change of -1 holder.
  • The largest Spruce Biosciences buyer in Q4 2023 was AIGH Capital Management, an estimated $1.41M added.
  • The largest Spruce Biosciences seller in Q4 2023 was Verition Fund Management, an estimated $2.98M sold.

Based on aggregated 13F filings for Q4 2023.